Novel new drug approvals in 2016 were half of what they were in 2015. How many were first in class? How many received priority review? Our infographic tells the tale:
Novel new drug approvals in 2016 were half of what they were in 2015. How many were first in class? How many received priority review? Our infographic tells the tale:
by Karin Hawkinson The Alzheimer's Association predicts that the number of Americans with Alzheimer's disease (AD)…
Hi, I'm Mary Calvagna, a Senior Learning Solutions Strategist at CLD. I've been designing and…